Our results suggest that higher levels of CR differentially mitigate APOE-ε4-related vs. AD-PRS-related cognitive decline, with the protective effect of CR being specific to APOE-ε4-related declines in episodic memory (but not executive function). This evidence concerns the gene APOE and Alzheimer disease.